Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Beraprost Sodium Modified Release in PAH
NCT00781885Phase 2Completed
- Sponsor
- Lung Biotechnology PBC
- Start
- Jan 2009
- Primary completion
- Sep 2010
- Modality
- Orthosteric Ligands
- Countries
- 3
01
Overview
A Phase 2 trial of beraprost in pulmonary arterial hypertension (PAH), sponsored by Lung Biotechnology PBC. Started Jan 2009; status: completed.
02
Drugs
beraprost
03
Conditions
pulmonary arterial hypertension (PAH)
Beyond the preview
Go deeper on NCT00781885.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00781885.